专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US4565948A Fluorescent lamp 失效
标题翻译：日光灯
公开(公告)号：US4565948A
公开(公告)日：1986-01-21
申请号：US474581
申请日：1983-02-16
申请人： Yoshio Kimura , Kenji Terashima , Masao Asada , Satoshi Sugano
发明人： Yoshio Kimura , Kenji Terashima , Masao Asada , Satoshi Sugano
IPC分类号： C09K11/08 , H01J61/44 , H01J1/63
CPC分类号： H01J61/44
摘要： A fluorescent lamp having a phosphor film comprising:a blue-emitting phosphor consisting essentially of at least one divalent europium activated haloborophosphate phosphor having the general formula:x(M.sub.1-p.Eu.sub.p.O).yP.sub.2 O.sub.5.aM'X.sub.2.bB.sub.2 O.sub.3 wherein M and M' are independently at least one of Sr, Ca and Ba; X is at least one of Cl, F and Br; and 2.7.ltoreq.x.ltoreq.3.3, 0.50.ltoreq.y.ltoreq.1.50, 0.10.ltoreq.a.ltoreq.0.50, 0.01.ltoreq.b.ltoreq.0.50, and 0.001.ltoreq.p.ltoreq.0.20;a green-emitting phosphor consisting essentially of a cerium and terbium activated silicophosphate phosphor of the general formula:(Re.sub.1-c-d-3e Tb.sub.c Ce.sub.d A.sub.3e).sub.2 O.sub.3.qP.sub.2 O.sub.5.rSiO.sub.2 wherein Re is at least one of Y, La and Gd; A is at least one of Li, Na, K, Rb, and Cs; and 0
摘要翻译： PCT No.PCT / JP82 / 00234 Sec。 371日期1983年2月16日 102（e）日期1983年2月16日PCT申请1982年6月18日PCT公布。公开号WO82 / 04439 日期为1982年12月23日。一种具有荧光膜的荧光灯，其特征在于，包括：基本上由至少一种具有通式x（M1-p.Eup.O）·yP2O5的二价铕活化卤代硼酸盐荧光体组成的蓝色发光荧光体。 aM'X2.bB2O3其中M和M'独立地是Sr，Ca和Ba中的至少一种; X是Cl，F和Br中的至少一个; 和2.7≤x≤3.3,0.50 / = e> / = 1×10-5,0 c + d + 3e <1,0,0 q，0

2. 发明授权

US4629582A Green-emitting phosphor 失效
标题翻译：绿色发光荧光粉
公开(公告)号：US4629582A
公开(公告)日：1986-12-16
申请号：US693317
申请日：1985-01-22
申请人： Kenji Terashima , Yoshio Kimura , Masao Asada , Satoshi Sugano
发明人： Kenji Terashima , Yoshio Kimura , Masao Asada , Satoshi Sugano
IPC分类号： C09K11/08 , C09K11/77 , C09K11/81 , C09K11/82 , H01J61/44
CPC分类号： C09K11/7774 , C09K11/7777
摘要： A green-emitting phosphor is activated by cerium and terbium and is represented by the general formula:(Re.sub.1-a-b-3c Tb.sub.a Ce.sub.b A.sub.3c).sub.2 O.sub.3.mP.sub.2 O.sub.5.nSiO.sub.2wherein Re is at least one member selected from the group consisting of yttrium, lanthanum, and gadolinium; A is at least one member selected from the group consisting of lithium (Li), sodium (Na), potassium (K), rubidium (Rb), and cesium (Cs); and a>0, b>0, c>0, 0 0, and n>0.The green-emitting phosphor of the invention may be widely applied to fluorescent lamps for copying machine light sources, or high luminous efficacy and high color rendering property fluorescent lamps such as three peak emission system fluorescent lamps.
摘要翻译： PCT No.PCT / JP82 / 00229 Sec。 371日期1983年2月14日 102（e）日期1983年2月14日PCT Filed 1982年6月16日PCT公布。公开号WO82 / 04438 日期为1982年12月23日。绿色发光荧光体由铈和铽活化，由通式表示：（Re1-ab-3cTbaCebA3c）2O3.mP2O5.nSiO2其中Re为选自以下的至少一种：的钇，镧和钆; A是选自锂（Li），钠（Na），钾（K），铷（Rb）和铯（Cs）中的至少一种; a> 0，b> 0，c> 0,0 = 5×10-2，m> 0，n> 0。本发明的绿色荧光体可以广泛地应用于复印机光源的荧光灯，或高发光效率的荧光灯，以及三峰发光系统荧光灯等高显色性荧光灯。

3. 发明授权

US4500443A Blue-green emitting halophosphate phosphor 失效
标题翻译：蓝绿色发射卤代磷酸盐荧光粉
公开(公告)号：US4500443A
公开(公告)日：1985-02-19
申请号：US617940
申请日：1984-06-08
申请人： Akira Taya , Kazuo Narita , Masao Asada , Yoshio Kimura
发明人： Akira Taya , Kazuo Narita , Masao Asada , Yoshio Kimura
IPC分类号： C09K11/71 , C09K11/73 , C09K11/77 , H01J61/44 , C09K11/465
CPC分类号： C09K11/7739 , C09K11/71 , H01J61/44
摘要： Disclosed is a blue-green emitting halophosphate phosphor activated with divalent europium, which is represented by the general formula:M.sub.5-x X(PO.sub.4).sub.3 :Eu.sup.2+.sub.(x)wherein M consists of Ba, Ca and Mg, X is one or more of F, Cl or Br, and x is a positive number of less than 5.
摘要翻译：公开了用二价铕活化的蓝绿色发射卤代磷酸盐荧光体，其由通式M5-xX（PO4）3：Eu2 +（x）表示，其中M由Ba，Ca和Mg组成，X是一种或多种 F，Cl或Br，x是小于5的正数。

4. 发明授权

US4287229A Method for surface treatment of phosphor particles 失效
标题翻译：磷光体颗粒表面处理方法
公开(公告)号：US4287229A
公开(公告)日：1981-09-01
申请号：US090922
申请日：1979-11-05
申请人： Minoru Watanabe , Mitsuhiro Oikawa , Toshio Nishimura , Masao Asada , Masao Tezuka , Tsurahide Cho
发明人： Minoru Watanabe , Mitsuhiro Oikawa , Toshio Nishimura , Masao Asada , Masao Tezuka , Tsurahide Cho
IPC分类号： C09K11/08 , C09K11/02 , H01J29/20 , H01J29/28 , H01J61/42 , H01J29/26
CPC分类号： C09K11/025 , Y10T428/2993
摘要： Disclosed is a method for surface treatment of phosphor particles which comprises forming a continuous film of silicon dioxide on the surface of each phosphor particle by treating the phosphor particle with a solution containing an aqueous solution of organic alkali and silicon dioxide dissolved therein.
摘要翻译：公开了一种用于表面处理荧光体颗粒的方法，其包括通过用溶解有机碱和二氧化硅水溶液的溶液处理荧光体颗粒，在每个荧光体颗粒的表面上形成连续的二氧化硅膜。

5. 发明申请

US20080118978A1 Anti-tumor agent 审中-公开
标题翻译：抗肿瘤剂
公开(公告)号：US20080118978A1
公开(公告)日：2008-05-22
申请号：US11730194
申请日：2007-03-29
申请人： Takashi Sato , Hiroyuki Ishida , Masao Asada , Takaaki Uochi , So Ohta
发明人： Takashi Sato , Hiroyuki Ishida , Masao Asada , Takaaki Uochi , So Ohta
IPC分类号： C12N5/06
CPC分类号： C07K16/40 , C07K16/2887 , C07K2317/24 , C07K2317/56 , C07K2317/565 , C07K2317/567 , C07K2317/732 , C07K2317/734
摘要： The present invention provides an agent which is effective to a patient who is administered by an agent comprising anti-CD20 antibody as an active ingredient.
摘要翻译：本发明提供一种对于由包含抗CD20抗体作为活性成分的药剂施用的患者有效的药剂。

6. 发明申请

US20090226399A1 MEDICAMENTS COMPRISING GENE RECOMBINANT ANTIBODY AGAINST GANGLIOSIDE GD3 审中-公开
标题翻译：含有抗坏血酸GD3基因重组抗体的药物
公开(公告)号：US20090226399A1
公开(公告)日：2009-09-10
申请号：US12420142
申请日：2009-04-08
申请人： Kenya Shitara , Rinpei Niwa , Junji Kanazawa , Masao Asada
发明人： Kenya Shitara , Rinpei Niwa , Junji Kanazawa , Masao Asada
IPC分类号： A61K39/395 , A61K38/21 , A61P35/00
CPC分类号： C07K16/28 , A61K39/39558 , A61K2039/505 , C07K2317/24 , C07K2317/732 , C07K2317/734 , A61K2300/00
摘要： In order to obtain high therapeutic effects in treating malignant tumors, particularly melanoma, a new therapeutic method having less side effects, or a new therapeutic method which can provide further high therapeutic effects at conventional doses of agents has been desired.An object of the present invention is to provide a medicament which can provide higher therapeutic effects than any one of a gene recombinant antibody against ganglioside GD3 or the antibody fragment thereof alone, and a substance which activates an immunocomponent cell and a substance having an antitumor activity alone, by combining a gene recombinant antibody against ganglioside GD3 or the antibody fragment thereof with at least one of a substance which activates an immunocomponent cell and a substance having an antitumor activity. Also, the medicament is expected to relieve side effects which were problems in the case of administration of individual single agents.
摘要翻译：为了在治疗恶性肿瘤，特别是黑素瘤中获得高治疗效果，期望具有较少副作用的新治疗方法或可以在常规剂量的试剂中提供更高治疗效果的新治疗方法。本发明的目的是提供一种可以提供比单独的针对神经节苷脂GD3的基因重组抗体或其单独的抗体片段的任何一种更高的治疗效果的药物，以及激活免疫组分细胞的物质和具有抗肿瘤活性的物质通过将基因重组抗体与神经节苷脂GD3或其抗体片段与激活免疫组分细胞的物质和具有抗肿瘤活性的物质中的至少一种组合。此外，预期药物可以减轻在给予单个单一药剂的情况下是问题的副作用。

7. 发明申请

US20080166345A1 MEDICAMENTS COMPRISING GENE RECOMBINANT ANTIBODY AGAINST GANGLIOSIDE GD3 审中-公开
标题翻译：含有抗坏血酸GD3基因重组抗体的药物
公开(公告)号：US20080166345A1
公开(公告)日：2008-07-10
申请号：US12033516
申请日：2008-02-19
申请人： Kenya SHITARA , Rinpei Niwa , Junji Kanazawa , Masao Asada
发明人： Kenya SHITARA , Rinpei Niwa , Junji Kanazawa , Masao Asada
IPC分类号： A61K39/395 , A61P35/04
CPC分类号： C07K16/28 , A61K39/39558 , A61K2039/505 , C07K2317/24 , C07K2317/732 , C07K2317/734 , A61K2300/00
摘要： In order to obtain high therapeutic effects in treating malignant tumors, particularly melanoma, a new therapeutic method having less side effects, or a new therapeutic method which can provide further high therapeutic effects at conventional doses of agents has been desired.An object of the present invention is to provide a medicament which can provide higher therapeutic effects than any one of a gene recombinant antibody against ganglioside GD3 or the antibody fragment thereof alone, and a substance which activates an immunocomponent cell and a substance having an antitumor activity alone, by combining a gene recombinant antibody against ganglioside GD3 or the antibody fragment thereof with at least one of a substance which activates an immunocomponent cell and a substance having an antitumor activity. Also, the medicament is expected to relieve side effects which were problems in the case of administration of individual single agents.
摘要翻译：为了在治疗恶性肿瘤，特别是黑素瘤中获得高治疗效果，期望具有较少副作用的新治疗方法或可以在常规剂量的试剂中提供更高治疗效果的新治疗方法。本发明的目的是提供一种可以提供比单独的针对神经节苷脂GD3的基因重组抗体或其单独的抗体片段的任何一种更高的治疗效果的药物，以及激活免疫组分细胞的物质和具有抗肿瘤活性的物质通过将基因重组抗体与神经节苷脂GD3或其抗体片段与激活免疫组分细胞的物质和具有抗肿瘤活性的物质中的至少一种组合。此外，预期药物可以减轻在给予单个单一药剂的情况下是问题的副作用。

8. 发明授权

US4527087A Fluorescent lamp 失效
标题翻译：日光灯
公开(公告)号：US4527087A
公开(公告)日：1985-07-02
申请号：US413242
申请日：1982-08-30
申请人： Akira Taya , Kazuo Narita , Jun-etsu Akiyama , Masao Asada , Hisami Nira
发明人： Akira Taya , Kazuo Narita , Jun-etsu Akiyama , Masao Asada , Hisami Nira
IPC分类号： C09K11/71 , C09K11/77 , H01J61/44
CPC分类号： C09K11/7739 , C09K11/71 , H01J61/44
摘要： Disclosed is a fluorescent lamp which comprises a mixture of a phosphor (i) comprising an alkaline earth metal halophosphate phosphor activated with divalent europium, represented by the general formula:M.sub.5-x X(PO.sub.4).sub.3 :Eu.sup.2+ (x)wherein M consists of Ba, Ca and Mg, containing 3 to 4.5 gram-atom of Ba, 0.5 to 2 gram-atom of Ca and 0.01 to 1 gram-atom of Mg each; X is one or more of F, Cl or Br; and 0.01
摘要翻译：公开了一种荧光灯，其包含由以下通式表示的由通式M5-xX（PO4）3：Eu2 +（x）表示的由二价铕活化的碱土金属卤化磷酸盐荧光体的荧光体（i）的混合物，其中M由Ba 含有3〜4.5克原子的Ba，0.5〜2克原子Ca和0.01〜1克原子的Mg的Ca和Mg， X是F，Cl或Br中的一种或多种; 和0.01

9. 发明申请

US20050260206A1 Drugs containing genetically modified antibody against ganglioside gd3 审中-公开
标题翻译：含有针对神经节苷脂gd3的转基因抗体的药物
公开(公告)号：US20050260206A1
公开(公告)日：2005-11-24
申请号：US10473037
申请日：2002-03-29
申请人： Kenya Shitara , Rinpei Niwa , Junji Kanazawa , Masao Asada
发明人： Kenya Shitara , Rinpei Niwa , Junji Kanazawa , Masao Asada
IPC分类号： A61K39/395 , A61P35/00 , C07K16/28
CPC分类号： C07K16/28 , A61K39/39558 , A61K2039/505 , C07K2317/24 , C07K2317/732 , C07K2317/734 , A61K2300/00
摘要： In order to obtain high therapeutic effects in treating malignant tumors, particularly melanoma, a new therapeutic method having less side effects, or a new therapeutic method which can provide further high therapeutic effects at conventional doses of agents has been desired. An object of the present invention is to provide a medicament which can provide higher therapeutic effects than any one of a gene recombinant antibody against ganglioside GD3 or the antibody fragment thereof alone, and a substance which activates an immunocomponent cell and a substance having an antitumor activity alone, by combining a gene recombinant antibody against ganglioside GD3 or the antibody fragment thereof with at least one of a substance which activates an immunocomponent cell and a substance having an antitumor activity. Also, the medicament is expected to relieve side effects which were problems in the case of administration of individual single agents.
摘要翻译：为了在治疗恶性肿瘤，特别是黑素瘤中获得高治疗效果，期望具有较少副作用的新治疗方法或可以在常规剂量的试剂中提供更高治疗效果的新治疗方法。本发明的目的是提供一种可以提供比单独的针对神经节苷脂GD3的基因重组抗体或其单独的抗体片段的任何一种更高的治疗效果的药物，以及激活免疫组分细胞的物质和具有抗肿瘤活性的物质通过将基因重组抗体与神经节苷脂GD3或其抗体片段与激活免疫组分细胞的物质和具有抗肿瘤活性的物质中的至少一种组合。此外，预期药物可以减轻在给予单个单一药剂的情况下是问题的副作用。

10. 发明授权

US4699662A Blue pigmented phosphor 失效
标题翻译：蓝色着色磷光体
公开(公告)号：US4699662A
公开(公告)日：1987-10-13
申请号：US878679
申请日：1986-06-26
申请人： Yoshiyuki Nakada , Masao Asada , Kiyoshi Inoue
发明人： Yoshiyuki Nakada , Masao Asada , Kiyoshi Inoue
IPC分类号： C09K11/08 , C09C1/32 , C09C3/12 , C09K11/02 , C09K11/69 , H01J29/20 , C04B14/00 , C08J3/00 , C08K3/34
CPC分类号： C09C1/32 , C09C3/12 , C09K11/025 , C01P2002/84 , C01P2004/80 , C01P2006/60
摘要： In ultramarine blue, or a blue pigmented phosphor in which ultramarine blue is a constituent, a coating of organic silicon compound is formed on the surface of the ultramarine blue pigment. This coating prevents fading of the ultramarine blue during the manufacture of cathode ray tubes.
摘要翻译：在群青蓝中，或者是群青蓝为成分的蓝色着色磷光体，在群青蓝色颜料的表面形成有机硅化合物的涂层。该涂层在阴极射线管的制造期间防止了群青蓝的褪色。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式